Journal
LIFE-BASEL
Volume 11, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/life11121304
Keywords
autophagy; autophagy inducers; autophagy inhibitors; autophagy regulation; chemotherapy; gastric cancer
Categories
Ask authors/readers for more resources
Gastric cancer is the fifth most common malignancy worldwide and many tumors display resistance to current chemotherapeutic agents. The interplay between gastric cancer development and the autophagy process is crucial, but the role of autophagy as either a tumor suppressor or promoter remains controversial.
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis, and strategies for clinical management. However, many gastric tumors appear to be resistant to current chemotherapeutic agents. Moreover, a significant number of gastric cancer patients, with a lack of optimal treatment strategies, have reduced survival. In recent years, multiple research data have highlighted the importance of autophagy, an essential catabolic process of cytoplasmic component digestion, in cancer. The role of autophagy as a tumor suppressor or tumor promoter mechanism remains controversial. The multistep nature of the autophagy process offers a wide array of targetable points for designing novel chemotherapeutic strategies. The purpose of this review is to summarize the current knowledge regarding the interplay between gastric cancer development and the autophagy process and decipher the role of autophagy in this kind of cancer. A plethora of different agents that direct or indirect target autophagy may be a novel therapeutic approach for gastric cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available